RAPIFEN

Safety category during pregnancy: "C": there are currently insufficient studies to confirm that the treatment is safe for the fetus; the treatment is used when the therapeutic benefit outweighs the risk to the fetus.

A doctor or pharmacist should be consulted before taking any treatment during pregnancy.

Use of the therapy in children has not been found to be effective or safe. "12 years.

The attending physician should be informed of the existence of any of the following illnesses or diseases.

In some cases it may be necessary to take special precautionary measures or change doses: disorders of the cardiac system, depression, collapse of the nervous system, injury, previous wear and tear to the head or brain, a state of alcoholism, treatment or other hypertoxic substance that can cause inertia, a decrease in hypertension, disorders of the cardiac system and muscular sclerosis, especially when treatment is administered with incorrect vibration (rapid amplification of the body).

The treatment must be under the supervision of a specialist doctor and a trainee, with the appropriate equipment to treat the patient in case of symptoms.

It serves as a pain care and treatment center for preoperative anesthesia.

A treatment may cause dependence when used in large or prolonged doses, and the patient may experience a steady increase in dose sufficient to relieve pain due to habituation of the body; You should follow your doctor's instructions on dose and method of treatment.

L'use of this substance in: patients who have shown hypersensitivity for treatment or any other element of this treatment prevents high intra-fracture pressure (high fluid tension in the skull, which can lead to a sharp decline in the respiratory system for various reasons, such as shocks A, some treatments).